Autolus Therapeutics plc (AUTL) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-13
6:41 pm
Unchanged
2023-12-3113GAutolus Therapeutics plc
AUTL
Syncona Portfolio Ltd33,527,162
14.400%
0
(Unchanged)
Filing
History
2024-01-31
4:10 pm
Sale
2023-12-3113GAutolus Therapeutics plc
AUTL
Tetragon Financial Management LP8,000,000
4.600%
-1,461,883decrease
(-15.45%)
Filing
History
2023-07-10
5:00 pm
Purchase
2023-06-3013GAutolus Therapeutics plc
AUTL
Paradigm BioCapital Advisors LP10,098,584
5.800%
10,098,584increase
(New Position)
Filing
History
2023-03-20
09:13 am
Purchase
2023-03-0913GAutolus Therapeutics plc
AUTL
Tetragon Financial Management LP9,461,883
5.500%
9,461,883increase
(New Position)
Filing
History
2023-02-14
5:02 pm
Purchase
2022-12-3113GAutolus Therapeutics plc
AUTL
Nantahala Capital Management, LLC7,782,018
4.700%
3,704,509increase
(+90.85%)
Filing
History
2023-02-14
12:09 pm
Purchase
2022-12-3113GAutolus Therapeutics plc
AUTL
Frazier Life Sciences Public Fund, L.P.3,746,857
2.200%
16,200increase
(+0.43%)
Filing
History
2023-02-14
12:02 pm
Purchase
2022-12-3113GAutolus Therapeutics plc
AUTL
Armistice Capital, LLC10,224,000
5.910%
10,224,000increase
(New Position)
Filing
History
2023-02-14
10:28 am
Purchase
2022-12-3113GAutolus Therapeutics plc
AUTL
Syncona Portfolio Ltd33,527,162
19.700%
14,000,000increase
(+71.70%)
Filing
History
2023-02-14
08:30 am
Unchanged
2022-12-3113GAutolus Therapeutics plc
AUTL
Deep Track Capital, LP15,000,000
8.670%
0
(Unchanged)
Filing
History
2023-02-13
2:49 pm
Sale
2023-02-1413GAutolus Therapeutics plc
AUTL
Capital World Investors625,000
0.400%
-2,330,806decrease
(-78.86%)
Filing
History
2022-12-19
4:11 pm
Purchase
2022-12-0913GAutolus Therapeutics plc
AUTL
Deep Track Capital, LP15,000,000
9.030%
15,000,000increase
(New Position)
Filing
History
2022-12-13
4:51 pm
Purchase
2022-12-0813DAutolus Therapeutics plc
AUTL
Blackstone Inc.
BX
23,750,917
14.000%
2,500,000increase
(+11.76%)
Filing
History
2022-12-13
4:50 pm
Purchase
2022-12-0913GAutolus Therapeutics plc
AUTL
Qatar Investment Authority15,000,000
9.030%
15,000,000increase
(New Position)
Filing
History
2022-10-05
4:21 pm
Purchase
2022-09-2313DAutolus Therapeutics plc
AUTL
PPF Biotech B.V.14,613,275
16.100%
1,000increase
(+0.01%)
Filing
History
2022-02-14
5:03 pm
Purchase
2021-12-3113GAutolus Therapeutics plc
AUTL
Nantahala Capital Management, LLC4,077,509
5.600%
4,077,509increase
(New Position)
Filing
History
2022-02-11
12:21 pm
Purchase
2021-12-3113GAutolus Therapeutics plc
AUTL
Syncona Portfolio Ltd19,527,162
26.800%
3,571,428increase
(+22.38%)
Filing
History
2021-12-17
2:37 pm
Purchase
2021-12-1313GAutolus Therapeutics plc
AUTL
Frazier Life Sciences Public Fund, L.P.3,730,657
5.100%
3,730,657increase
(New Position)
Filing
History
2021-11-16
4:07 pm
Purchase
2021-11-0613DAutolus Therapeutics plc
AUTL
Blackstone Inc.
BX
21,250,917
22.600%
21,250,917increase
(New Position)
Filing
History
2021-06-23
4:00 pm
Purchase
2021-05-1813DAutolus Therapeutics plc
AUTL
PPF Biotech B.V.14,612,275
27.900%
361,255increase
(+2.53%)
Filing
History
2021-02-17
5:01 pm
Sale
2021-02-1213DAutolus Therapeutics plc
AUTL
Arix Bioscience plc3,319,866
4.800%
-50,000decrease
(-1.48%)
Filing
History
Goto Prev, 0, 1, 2, Next